Tarsus Pharmaceuticals, Inc. - Common Stock — Cash Flow (NASDAQ:TARS) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -21.14 M3.75 M-49.03 M-117.49 M-83.03 M-12.45 M -16.45 M Cash from investing activities -456 K-586 K-144.63 M140.6 M-199.19 M-42.12 M -65.73 M Cash from financing activities 131.77 M21 K93.99 M130.18 M154.66 M143.39 M 8.03 M Free cash flow -21.14 M3.75 M-49.03 M-117.49 M-83.03 M-22.31 M -31.54 M

News

Tarsus Q1 Review: Strong Earnings, But Wall Street Wanted A Guidance Raise (NASDAQ:TARS)

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Beats Revenue Estimates

Amgen (AMGN) Q1 Earnings and Revenues Beat Estimates

Tarsus Pharmaceuticals: Marketing Spend Bears Fruit, Pipeline Progresses (NASDAQ:TARS)

Gold Stocks, AI Leader Broadcom Among 25 Newcomers To Best Stock Lists

Tarsus Pharmaceuticals Stock Earns Upgrade To RS Rating

Cloudflare Qualifies For Two Top Stock Lists, Leads 13 Newcomers To IBD 50, Stock Spotlight, More

Tarsus Pharmaceuticals at Barclays Conference: Strategic Growth and Challenges

Tarsus Pharma COO Neervannan Seshadri sells $641k in stock

Tarsus Pharmaceuticals at TD Cowen Conference: Eyeing Blockbuster Growth

Maker Of Eye Drops Has Sights On Buy Point

Miners Barrick, Pan American Leads 10 Hot Growth Stocks Onto The IBD 50, Other Premium Lists